GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Cyclically Adjusted Price-to-FCF

Avid Bioservices (STU:TEHN) Cyclically Adjusted Price-to-FCF : (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Avid Bioservices Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Avid Bioservices's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Cyclically Adjusted Price-to-FCF Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avid Bioservices's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Avid Bioservices's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Cyclically Adjusted Price-to-FCF falls into.



Avid Bioservices Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Avid Bioservices's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Avid Bioservices's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.012/130.1244*130.1244
=-0.012

Current CPI (Jan. 2024) = 130.1244.

Avid Bioservices Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 -0.193 100.023 -0.251
201407 -0.404 100.520 -0.523
201410 -0.391 100.176 -0.508
201501 -0.386 98.604 -0.509
201504 -0.228 99.824 -0.297
201507 -0.591 100.691 -0.764
201510 -0.391 100.346 -0.507
201601 -0.305 99.957 -0.397
201604 -0.172 100.947 -0.222
201607 -0.481 101.524 -0.617
201610 0.009 101.988 0.011
201701 -0.313 102.456 -0.398
201704 -0.266 103.167 -0.336
201707 -0.244 103.278 -0.307
201710 -0.164 104.070 -0.205
201801 -0.163 104.578 -0.203
201804 0.007 105.708 0.009
201807 -0.117 106.324 -0.143
201810 -0.108 106.695 -0.132
201901 -0.061 106.200 -0.075
201904 0.086 107.818 0.104
201907 -0.040 108.250 -0.048
201910 0.079 108.577 0.095
202001 -0.043 108.841 -0.051
202004 0.037 108.173 0.045
202007 -0.042 109.318 -0.050
202010 0.118 109.861 0.140
202101 0.033 110.364 0.039
202104 0.180 112.673 0.208
202107 -0.148 115.183 -0.167
202110 0.040 116.696 0.045
202201 -0.205 118.619 -0.225
202204 -0.244 121.978 -0.260
202207 -0.186 125.002 -0.194
202210 -0.624 125.734 -0.646
202301 -0.245 126.223 -0.253
202304 -0.314 127.992 -0.319
202307 -0.207 128.974 -0.209
202310 -0.018 129.810 -0.018
202401 -0.012 130.124 -0.012

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avid Bioservices  (STU:TEHN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Avid Bioservices Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Industry
Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines